Guardant Health DEF 14A: Executive Comp & Governance
Ticker: GH · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, corporate-governance, shareholder-meeting
Related Tickers: GH
TL;DR
Guardant Health's DEF 14A is out, detailing exec pay and stock awards for 2024. Check it for governance insights.
AI Summary
Guardant Health, Inc. filed its DEF 14A on April 29, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted and vested, as well as adjustments to equity awards for non-personnel and non-executive officers. Specific details on dollar amounts and dates for these compensation elements are provided within the extensive filing.
Why It Matters
This filing provides shareholders with crucial information regarding how executive compensation is structured and awarded, impacting company performance and investor confidence.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine but can reveal significant details about executive compensation, potential shareholder proposals, or changes in corporate governance that could impact stock value.
Key Players & Entities
- Guardant Health, Inc. (company) — Filer of the DEF 14A
- Helmy Eltoukhy (person) — Mentioned in relation to equity awards and fiscal years
- Amirali Talasaz (person) — Mentioned in relation to equity awards and fiscal years
FAQ
What is the primary purpose of this DEF 14A filing for Guardant Health, Inc.?
The primary purpose is to provide shareholders with information regarding the company's annual meeting, including details on executive compensation, director nominations, and other corporate governance matters, as required by SEC regulations.
What fiscal year does the compensation information in this filing primarily cover?
The compensation information primarily covers the fiscal year ending December 31, 2024, with references to prior years for context on awards and vesting.
Are there specific individuals named in relation to equity awards?
Yes, individuals such as Helmy Eltoukhy and Amirali Talasaz are mentioned in the context of equity awards granted and vested during specific fiscal years.
What type of equity awards are discussed in the filing?
The filing discusses various equity awards including those granted and vested, and adjustments to equity awards for non-personnel and non-executive officers.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 29, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 by Helmy Eltoukhy regarding Guardant Health, Inc. (GH).